Reliable assessment of atopic dermatitis severity: do we need more tools?

Reich, Adam

doi:10.1111/bjd.19392

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These can be collected outside of scheduled office visits, thereby enhancing the understanding of the patient's disease between physician visits. AD's complexity and heterogeneity have led to the development of many measures for its assessment; however, none are considered the gold standard for assessing severity in clinical practice [48]. Studies show that a reliable assessment of AD severity requires applying at least two independent tools concomitantly [49].…”

Section: Measurement Toolsmentioning

confidence: 99%

The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective

Sánchez

Chérrez-Ojeda

Galván

et al. 2021

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Introduction: Adoption of control tools for atopic dermatitis (AD) in Latin America (LA) is currently very limited. Clinical assessment tools represent a practical method to measure the impact of treatment on disease activity and on the quality of life of patients. However, the use of these tools in the LA clinical practice setting is limited. Methods: A selected panel of Latin American experts in fields related to atopic dermatitis were provided with a series of relevant questions to address prior to the multi-day conference. Within this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved. Results: The panel proposes specific and realistic recommendations for implementing control tools for AD care in LA. In creating these recommendations, the authors strove to address all barriers to the widespread use of these tools. Conclusion: This article includes a narrative analysis of barriers to AD control in LA and

show abstract

Section: Measurement Toolsmentioning

confidence: 99%